Selective serotonin reuptake inhibitor use and breast cancer survival: a population-based cohort study

John Busby, Ken Mills, Shu-Dong Zhang, Fabio Giuseppe Liberante, Chris R. Cardwell

Research output: Contribution to journalArticlepeer-review

34 Citations (Scopus)
Original languageEnglish
JournalBreast Cancer Research
Volume20
Issue number1
DOIs
Publication statusPublished (in print/issue) - 19 Jan 2018

Keywords

  • Selective serotonin reuptake inhibitors
  • Breast cancer
  • Progression
  • Survival
  • Pharmacoepidemiology

Cite this